Literature DB >> 18234132

Influences of weight loss on long-term diabetes outcomes.

Lorna S Aucott1.   

Abstract

Increasing rates of type 2 diabetes (T2DM) follow the obesity 'epidemic', with 86% of patients with T2DM being overweight and over half being obese. Literature has highlighted that being overweight or obese increases the risk of diabetes. Weight loss for obese patients is associated with clinical improvements, although this evidence is mostly from short-term studies. As part of a Health Technology Assessment systematic review the long-term (> or =2 years) effects of weight loss on change in diabetes-related outcome measures for those with diabetes, or risk of developing diabetes for those without diabetes, was investigated in obese individuals. Eleven studies published between 1966 and 2001 fulfilled the inclusion criteria (Caucasian, BMI >28 kg/m2, adults, no eating disorders, weight loss and changes in diabetes-outcome measures). Results of these studies indicated that intentional weight loss reduces the risk of developing diabetes in the long term and those participants with T2DM often have reduced clinical symptoms and mortality risk. These results have been verified and enhanced by literature published since this review. A similar systematic review was conducted as part of a six-phase project, the PRevent Obesity GRowing Economic Synthesis Study. This review excluded BMI >34 kg/m2 and was restricted to lifestyle interventions (or intentional weight loss). Limited information relating to diabetes was gained, with only a non-significant increasing trend for mortality from diabetes for severe weight cycling practices being suggested. Other results indicated a relationship between weight loss and fasting plasma glucose, but because of the heterogeneity of participation groups and lack of definition in relation to diabetes this relationship was not formalised. In summary, weight loss is beneficial for long-term diabetes outcomes for overweight, obese and morbidly-obese participants. There is little research evidence for those individuals who are overweight or just obese, indicating areas of future research in terms of prevention of both obesity and diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18234132     DOI: 10.1017/S0029665108006022

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  19 in total

Review 1.  Impact of weight cycling on risk of morbidity and mortality.

Authors:  T Mehta; D L Smith; J Muhammad; K Casazza
Journal:  Obes Rev       Date:  2014-09-29       Impact factor: 9.213

2.  Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes.

Authors:  Tamae Takato; Kai Iwata; Chiaki Murakami; Yuko Wada; Fumio Sakane
Journal:  Diabetologia       Date:  2017-07-13       Impact factor: 10.122

3.  Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.

Authors:  Carel le Roux; Vanita Aroda; Joanna Hemmingsson; Ana Paula Cancino; Rune Christensen; Xavier Pi-Sunyer
Journal:  Obes Facts       Date:  2017-11-17       Impact factor: 3.942

4.  Similarities and differences between diabetic and idiopathic gastroparesis.

Authors:  Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Jorge Calles; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

Review 5.  Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.

Authors:  Faidon Magkos; Mary Yannakoulia; Jean L Chan; Christos S Mantzoros
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

6.  GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.

Authors:  Samantha M Fortin; Rachele K Lipsky; Rinzin Lhamo; Jack Chen; Eun Kim; Tito Borner; Heath D Schmidt; Matthew R Hayes
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

7.  Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice.

Authors:  Zhi-Hong Yang; Hiroko Miyahara; Jiro Takeo; Masashi Katayama
Journal:  Diabetol Metab Syndr       Date:  2012-07-04       Impact factor: 3.320

8.  Neighborhood deprivation and change in BMI among adults with type 2 diabetes: the Diabetes Study of Northern California (DISTANCE).

Authors:  Pamela J Stoddard; Barbara A Laraia; E Margaret Warton; Howard H Moffet; Nancy E Adler; Dean Schillinger; Andrew J Karter
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

9.  Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes.

Authors:  Zhi-Hong Yang; Hiroko Miyahara; Akimasa Hatanaka
Journal:  Lipids Health Dis       Date:  2011-07-21       Impact factor: 3.876

Review 10.  Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis.

Authors:  Anna Chudyk; Robert J Petrella
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.